<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2009</study_start_year><condition>unresectable metastatic colorectal cancer</condition><disease>Unresectable Metastatic Colorectal Cancer</disease><study_type>Observational</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/2617422</full_dataset_link><location>Japan</location><study_start_month>3</study_start_month><repository>ECRIN MDR</repository><study_status>Completed</study_status></additional><is_claimable>false</is_claimable><name>Evaluating amphiregulin in plasma for metastatic colorectal cancer treated with cetuximab based therapy</name><description>Primary outcome(s): disease control rate between higher and lower amphiregulin group</description><dates><creation>2009-03-15</creation></dates><accession>2617422</accession><cross_references><Japan Primary Registries Network>JPRN-UMIN000001934</Japan Primary Registries Network></cross_references></HashMap>